Urgent.News

What's breaking now, across thousands of outlets.

Business

Morepen Laboratories files its first US ANDA for sitagliptin tablets

The filing for sitagliptin tablets in three strengths marks Morepen's entry into integrated finished-dose development and regulatory filings in the US market

Morepen Laboratories files its first US ANDA for sitagliptin tablets

We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.

Read the original at business-standard.com →

More in Business

More from Monday 28 September →